Completed NA INTERVENTIONAL 3-arm NCT04813965

Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms (CONTEXT)

Downsides of Being Well-Informed: Tracking and Preventing Chemotherapy-Related Cognitive Problems in Breast Cancer Patients

Sponsor: Deventer Ziekenhuis

Conditions Breast Cancer Cognitive Decline Cognitive Symptoms

Interventions Written information about potential chemotherapy-related cognitive symptoms with self-affirmation Written information about potential chemotherapy-related cognitive symptoms without self-affirmation

Updated 4 times since 2021 Last updated: Mar 21, 2021 Started: Mar 20, 2014 Primary completion: Sep 23, 2016 Completion: Sep 23, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Cognitive Decline and is currently completed. Deventer Ziekenhuis leads this study, which shows 4 recorded versions since 2014 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2022 — Jul 2024 [monthly]

Completed NA
Apr 2021 — Mar 2022 [monthly]

Completed NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deventer Ziekenhuis
Franciscus Gasthuis
Isala
Meander Medical Center
Radboud University Medical Center
Rijnstate Hospital
St Jansdal Hospital
St. Antonius Hospital
The Netherlands Cancer Institute
UMC Utrecht
Ziekenhuisgroep Twente

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.